Document is current
Any future updates will be listed below
-
Authors
Montanaro, Elisa
Romagnolo, Alberto https://orcid.org/0000-0002-1312-1843
Fabbri, Margherita
Artusi, Carlo Alberto
Imbalzano, Gabriele
Rizzone, Mario Giorgio
Lopiano, Leonardo
Zibetti, Maurizio
-
Funding
Funding for this research was provided by:
Università degli Studi di Torino
- License Information
-
More Information
Article History
Received: 9 June 2021
Revised: 21 July 2021
Accepted: 24 July 2021
First Online: 30 July 2021
Declarations
:
: Dr. Montanaro has received travel grant from Ralpharma. Dr Romagnolo has received grant support and speaker honoraria from AbbVie, speaker honoraria from Chiesi Farmaceutici, and travel grants from Lusofarmaco, Chiesi Farmaceutici, Medtronic, and UCB Pharma. Dr Fabbri has received speaker honoraria from AbbVie. Dr. Artusi has received travel grants from Zambon and Abbvie, and educational grants from Ralpharma and Neuraxpharm. Dr. Imbalzano has no financial conflicts to disclose. Dr. Rizzone has received grant support and speaker honoraria from Medtronic and UCB. Dr. Lopiano has received honoraria for lecturing and travel grants from Medtronic, UCB Pharma, and AbbVie. Dr. Zibetti has received honoraria from Medtronic, Zambon Pharma, and AbbVie.
: The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. The local institutional review board (<i>Protocol number: 0025346 of 11 May 2016; Comitato Etico Interaziendale A.O.U. Città della Salute e della Scienza di Torino – A.O. Ordine Mauriziano di Torino – A.S.L. TO1</i>) approved the study and all participants provided written informed consent.
